OpenNashPodcasts

Topic

Inflation Reduction Act

5 facts from 4 episodes, in date order. These are what speakers said on the shows, each linked to the moment it was said. They aren't independently verified.

2022

Vas Narasimhan argues that the Inflation Reduction Act's nine years before price controls for small-molecule drugs is too short to allow indication expansions, rare disease work and oncology and cardiovascular development.

“we believe that the nine years of protection before price controls take hold in the small molecule space is simply too short to really allow us to do the indication expansions”

Vas Narasimhan · 246: Vas Narasimhan on the future of pharma, plus Moderna’s promise & a biotech presidential bid, 0:17:23

Undated

Dave Ricks said the Inflation Reduction Act, passed under the Biden administration, allows government price intervention on medicines roughly seven years after launch.

“the Biden administration passed a rule in the Inflation Reduction Act to actually have government price intervention in the US at five years plus two.”

Dave Ricks · Dave Ricks, CEO of Eli Lilly, on GLP-1s and the business of pharma, 0:34:12

Episodes